 Psychedelic-focused biotech company Mind Medicine Inc. NASDAQ:MNMD NEO: MMED DE: MMQ announced Tuesday that Robert Barrow has been appointed CEO and member of the board of directors. Barrow, an accomplished pharmaceutical executive and a recognized leader in the psychedelic industry, is bringing over a decade of experience leading organizations and drug development programs to the New York-based company. 